
Novel selenium-nonsteroidal anti-inflammatory препарат (Se-NSAID), inhibiting colorectal cancer (CRC) growth via the inhibition of the клетка cycle in G1 and G2/M phases and reduces the клетка cycle markers like cyclin E1 and B1 in a dose dependent manner
Novel selenium-nonsteroidal anti-inflammatory drug (Se-NSAID), inhibiting colorectal cancer (CRC) growth via the inhibition of the cell cycle in G1 and G2/M phases and reduces the cell cycle markers like cyclin E1 and B1 in a dose dependent manner
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.